Clarivate™ is a global leader in transformative intelligence, dedicated to empowering innovation through a comprehensive suite of research and analytics tools. Their flagship service, the Derwent World Patents Index (DWPI), offers in-depth patent data indexed by invention and application, enhanced with abstracts that illuminate the invention's novelty and advantages. Clarivate supports various sectors, including academia, government, and biopharma, with integrated, AI-enabled solutions such as the OFF-X™ platform for preclinical and clinical safety intelligence and the Cortellis suite for drug discovery and competitive intelligence.

Their commitment to sustainability and collaboration drives their mission to facilitate research excellence and enhance decision-making for innovators and researchers worldwide. With a focus on cutting-edge AI technology and a robust acquisition strategy, including the recent purchase of Rowan TELS, Clarivate continuously evolves to meet the dynamic needs of its diverse clientele. They aim to provide valuable insights and analytics to accelerate impactful research and development.